A Secret Weapon For who makes the diabetes drug copyright
• to lessen the potential risk of really serious cardiovascular (heart and blood vessel) problems in Grown ups with variety two diabetes and cardiovascular diseaseIn October 2024, Novo Nordisk printed a review on scientific journal Mother nature about a novel glucose-sensitive insulin NNC2215 that will cut down the risk of hypoglycemia in animal